(NASDAQ: OPK) Opko Health's forecast annual revenue growth rate of 4.02% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.
Opko Health's revenue in 2025 is $713,142,000.On average, 5 Wall Street analysts forecast OPK's revenue for 2025 to be $447,674,213,390, with the lowest OPK revenue forecast at $427,441,746,855, and the highest OPK revenue forecast at $459,877,624,896. On average, 4 Wall Street analysts forecast OPK's revenue for 2026 to be $482,431,640,714, with the lowest OPK revenue forecast at $422,405,119,830, and the highest OPK revenue forecast at $523,137,660,330.
In 2027, OPK is forecast to generate $545,085,937,804 in revenue, with the lowest revenue forecast at $528,241,442,382 and the highest revenue forecast at $576,458,751,768.